These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 15665683)
1. Dynamic subtraction magnetic resonance imaging of cirrhotic liver: assessment of high signal intensity lesions on nonenhanced T1-weighted images. Yu JS; Kim YH; Rofsky NM J Comput Assist Tomogr; 2005; 29(1):51-8. PubMed ID: 15665683 [TBL] [Abstract][Full Text] [Related]
2. T2-weighted MR imaging in the assessment of cirrhotic liver. Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306 [TBL] [Abstract][Full Text] [Related]
3. T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging. Kim S; Jain M; Harris AB; Lee VS; Babb JS; Sigmund EE; Rueff LE; Taouli B Radiology; 2009 Jun; 251(3):796-807. PubMed ID: 19380690 [TBL] [Abstract][Full Text] [Related]
4. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction. Choi N; Han BK; Choe YH; Kim HS J Comput Assist Tomogr; 2005; 29(6):834-41. PubMed ID: 16272861 [TBL] [Abstract][Full Text] [Related]
5. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging. Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584 [TBL] [Abstract][Full Text] [Related]
6. Small hyperintense hepatic lesions on T1-weighted images in patients with cirrhosis: evaluation with serial MRI and imaging features for clinical benignity. Shimizu A; Ito K; Sasaki K; Hayashida M; Tanabe M; Shimizu K; Matsunaga N Magn Reson Imaging; 2007 Dec; 25(10):1430-6. PubMed ID: 17524587 [TBL] [Abstract][Full Text] [Related]
7. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images. Wang YC; Chou CT; Lin CP; Chen YL; Chen YF; Chen RC PLoS One; 2017; 12(3):e0174594. PubMed ID: 28355258 [TBL] [Abstract][Full Text] [Related]
8. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. Chiu FY; Jao JC; Chen CY; Liu GC; Jaw TS; Chiou YY; Hsu FO; Hsu JS J Comput Assist Tomogr; 2005; 29(2):176-80. PubMed ID: 15772533 [TBL] [Abstract][Full Text] [Related]
9. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287 [TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317 [TBL] [Abstract][Full Text] [Related]
11. Hepatic lesions: morphologic and functional characterization with multiphase breath-hold 3D gadolinium-enhanced MR angiography--initial results. Hawighorst H; Schoenberg SO; Knopp MV; Essig M; Miltner P; van Kaick G Radiology; 1999 Jan; 210(1):89-96. PubMed ID: 9885592 [TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced magnetization transfer MR of the brain: importance of precontrast images. Meyer JR; Androux RW; Salamon N; Rabin B; Callahan C; Parrish TB; Prager J; Russell EJ AJNR Am J Neuroradiol; 1997 Sep; 18(8):1515-21. PubMed ID: 9296193 [TBL] [Abstract][Full Text] [Related]
13. Distinguishing hemangiomas from malignant solid hepatic lesions: a comparison of heavily T2-weighted images obtained before and after administration of gadoxetic acid. Ahn SJ; Kim MJ; Hong HS; Kim KA; Song HT J Magn Reson Imaging; 2011 Aug; 34(2):310-7. PubMed ID: 21598345 [TBL] [Abstract][Full Text] [Related]
14. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media]. Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451 [TBL] [Abstract][Full Text] [Related]
15. Clinical Feasibility of Free-Breathing Dynamic T1-Weighted Imaging With Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging Using a Combination of Variable Density Sampling and Compressed Sensing. Yoon JH; Yu MH; Chang W; Park JY; Nickel MD; Son Y; Kiefer B; Lee JM Invest Radiol; 2017 Oct; 52(10):596-604. PubMed ID: 28492418 [TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T1 shortening. Janardhan V; Suri S; Bakshi R Radiology; 2007 Sep; 244(3):823-31. PubMed ID: 17690319 [TBL] [Abstract][Full Text] [Related]
18. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Hecht EM; Israel GM; Krinsky GA; Hahn WY; Kim DC; Belitskaya-Levy I; Lee VS Radiology; 2004 Aug; 232(2):373-8. PubMed ID: 15215544 [TBL] [Abstract][Full Text] [Related]
19. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging. Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015 [TBL] [Abstract][Full Text] [Related]
20. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI. Mortelé KJ; Praet M; Van Vlierberghe H; de Hemptinne B; Zou K; Ros PR Abdom Imaging; 2002; 27(6):700-7. PubMed ID: 12395259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]